Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 377 of 1,261

  1. US 10870645

    Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

    Valo Early Discovery, Inc. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  2. US 10870625

    Zwitterionic propargyl-linked antifolates useful for treating bacterial infections

    UNIVERSITY OF CONNECTICUT · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  3. US 10870632

    Process for producing an extract containing tetrahydrocannabinol and cannabidiol from cannabis plant material, and cannabis extracts

    BIONORICA ETHICS GMBH · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  4. US 10870652

    Compounds and methods for modulating bruton's tyrosine kinase

    Corvus Pharmaceuticals, Inc. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  5. US 10869948

    Composition of collagen peptide and elastin peptide, method of producing the same and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  6. US 10869933

    Oligomer-phenothiazine conjugates

    Nektar Therapeutics · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  7. US 10869880

    Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying agents useful therefor

    The Regents of the University of California · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  8. US 10869866

    Benzathine analogs

    United States Government as represented by the Department of Veterans Affairs · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  9. US 10869871

    Compositions and methods of modulating short-chain dehydrogenase activity

    The Board of Regents of the University of Texas System · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  10. US 10869902

    Cured gel and method of making

    ATRIUM MEDICAL CORPORATION · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  11. US 10869865

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Serv · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  12. US 10869863

    Multi-arm polymeric targeting anti-cancer conjugate

    BrightGene Bio-Medical Technology Co., Ltd. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  13. US 10869841

    Nanoscale coatings for encapsulation of biological entities

    The Regents of the University of California · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  14. US 10869911

    Chimeric protein

    AUTOLUS LIMITED · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  15. US 10869846

    N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress

    SENTIENT LIFESCIENCES, INC. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  16. US 10869856

    Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  17. WO 2020249818

    PROCÉDÉ DE TRAITEMENT DU CANCER PAR DÉPÔT INTRATUMORAL DE MICROPARTICULES RADIOACTIVES

    ADVANCED ACCELERATOR APPLICATIONS [FR] · Granted Dec 17, 2020 · Expires Dec 12, 2040

    granted

  18. US 10865215

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  19. US 10865403

    Engineered primate cystine/cysteine degrading enzymes for therapeutic uses

    The Board of Regents of the University of Texas System · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  20. US 10864276

    Activated polyoxazolines and conjugates and compositions comprising the same

    Serina Therapeutics, Inc. · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  21. US 10867702

    Individual and cohort pharmacological phenotype prediction platform

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  22. US 10864206

    Treatment of neurodegenerative conditions by disruption of Rhes

    The Regents of the University of California · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  23. US 10864152

    TRPV3 agonists for the treatment of skin conditions

    Soricimed Biopharma Inc. · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  24. US 10864254

    Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.